Medications

Novel vaccine may yield affordable solution to lipid disorders

Dyslipidemia is a major risk factor for cardiovascular disease, which can significantly shorten life expectancy. Recently, Prof. Yuichi Oike and his team of scientists at Kumamoto University, Japan, have successfully developed ...

Diabetes

Treatment effect of fenofibrate varies in patients with T2DM

(HealthDay)—For individual patients with type 2 diabetes mellitus (T2DM), the effect of fenofibrate treatment varies and is larger in patients with dyslipidemia, according to a study published online Feb. 22 in Diabetes ...

Diabetes

HbA1c, waist-to-height ratio predict dyslipidemia in T1DM

(HealthDay)—For youth with type 1 diabetes, hemoglobin A1c (A1C) and waist-to-height ratio (WHtR) are modifiable risk factors that predict change in dyslipidemia, according to a study published online Jan. 26 in Diabetes ...

Cardiology

High incidence of cardiovascular risk factors in older adults

(HealthDay)—Older adults have high incidence of cardiovascular risk factors, with increased incidence of hypertension, diabetes mellitus, and dyslipidemia for blacks, according to a study published online Sept. 26 in the ...

HIV & AIDS

Limited evidence on management of dyslipidemia in HIV

(HealthDay)—A detailed guide has been presented for clinicians who manage dyslipidemia in HIV-infected patients. The guide, based on and extrapolated from guidelines for the general population, has been published online ...

page 1 from 3

Dyslipidemia

Dyslipidemia or dyslipidaemia is an abnormal amount of lipids (e.g. cholesterol and/or fat) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood, often due to diet and lifestyle. The prolonged elevation of insulin levels can lead to dyslipidemia. Increased levels of O-GlcNAc transferase (OGT) are known to cause dyslipidemia.[1]

This text uses material from Wikipedia, licensed under CC BY-SA